טוען...

Hesperetin reverses P-glycoprotein-mediated cisplatin resistance in DDP-resistant human lung cancer cells via modulation of the nuclear factor-κB signaling pathway

Lung cancer is the leading cause of cancer-associated mortality worldwide. Cisplatin (DDP) is a first-line chemotherapeutic drug for the treatment of lung cancer; however, the majority of patients develop resistance to DDP. P-glycoprotein (P-gp), also referred to as multidrug resistance (MDR) protei...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Int J Mol Med
Main Authors:	Kong, Wencui, Ling, Xiaoming, Chen, Ying, Wu, Xiaoli, Zhao, Zhongquan, Wang, Wenwu, Wang, Shuiliang, Lai, Guoxiang, Yu, Zongyang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	D.A. Spandidos 2020
נושאים:	Articles
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7053858/ https://ncbi.nlm.nih.gov/pubmed/32124932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2020.4485
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Hesperetin reverses P-glycoprotein-mediated cisplatin resistance in DDP-resistant human lung cancer cells via modulation of the nuclear factor-κB signaling pathway

פריטים דומים